Daniel L. Korpolinski
Direktor/Vorstandsmitglied bei ImmuLogic Pharmaceutical Corp.
Profil
DANIEL L.
KORPOLINSKI has been the President and Chief Executive Officer, U.S.
Operations, since March 2000, and as one of our Director, President and Chief Executive Officer from May 2000.
He was President and Chief Executive Officer of Copley Pharmaceutical Inc., a generic pharmaceutical company, from September 1998 until the company was acquired by Teva Pharmaceutical Industries Ltd.
in September 1999.
He was also a director of Copley from August 1998 until its acquisition.
Between 1991 and 1996, he served as the President and Chief Executive Officer of CoCensys Inc., a biotechnology company specializing in the development of therapeutics for the central nervous system.
From 1988 to 1991, Mr. Korpolinski was President of Adria Laboratories North America, an oncology company.
He started his career in the pharmaceutical industry with the Upjohn Company, where he spent 24 years, ultimately in the capacity as an Executive Director of several pharmaceutical business groups.
He received his B.S.
from Niagra University in New York.
Aktive Positionen von Daniel L. Korpolinski
| Unternehmen | Position | Beginn |
|---|---|---|
ImmuLogic Pharmaceutical Corp.
 ImmuLogic Pharmaceutical Corp. Pharmaceuticals: MajorHealth Technology ImmuLogic Pharmaceutical Corporation is a biopharmaceutical company. The company focuses on the research and clinical development of products to treat allergies, autoimmune diseases, and vaccines for the management of drugs of abuse. It was founded on March 26, 1987 and is headquartered in Woburn, MN. | Direktor/Vorstandsmitglied | 13.04.2010 |
Ehemalige bekannte Positionen von Daniel L. Korpolinski
| Unternehmen | Position | Ende |
|---|---|---|
| GVIC COMMUNICATIONS CORP. | Präsident | 23.03.2006 |
Nventa Biopharmaceuticals Corp.
 Nventa Biopharmaceuticals Corp. Medical SpecialtiesHealth Technology Nventa Biopharmaceuticals Corp. discovered, developed and commercialized stress protein-based therapeutic vaccines. The company was headquartered in Victoria, Canada. | Präsident | - |
Erfahrungen
Besetzte Positionen
Aktive
Inaktive
Börsennotierte Unternehmen
Private Unternehmen
Beziehungen
Beziehungen ersten Grades
Unternehmen ersten Grades
Herr
Frau
Aufsichtsräte
Führungskräfte
Unternehmensverbindungen
| Private Unternehmen | 3 |
|---|---|
Nventa Biopharmaceuticals Corp.
Nventa Biopharmaceuticals Corp. Medical SpecialtiesHealth Technology Nventa Biopharmaceuticals Corp. discovered, developed and commercialized stress protein-based therapeutic vaccines. The company was headquartered in Victoria, Canada. | Health Technology |
GVIC Communications Corp.
 GVIC Communications Corp. Publishing: NewspapersConsumer Services GVIC Communications Corp. operates as an information and marketing solutions company. The firm engages in the provision of information and related services through print and digital media. It operates through following segments: Environmental and Property Information, Commodity Information and Community Media. The company was founded in 1990 and is headquartered in Vancouver, Canada. | Consumer Services |
ImmuLogic Pharmaceutical Corp.
ImmuLogic Pharmaceutical Corp. Pharmaceuticals: MajorHealth Technology ImmuLogic Pharmaceutical Corporation is a biopharmaceutical company. The company focuses on the research and clinical development of products to treat allergies, autoimmune diseases, and vaccines for the management of drugs of abuse. It was founded on March 26, 1987 and is headquartered in Woburn, MN. | Health Technology |
